Immucell (ICCC) Stock: Buy, Sell, or Hold?
ICCC - Immucell Corp
$10.52
0.07 (0.67%)
▲
5d:
-2.14%
30d:
+5.31%
90d:
-3.75%
WAIT
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 12, 2026
20d
Get Alerted When ICCC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ICCC shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ICCC shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: ICCC is currently trading at $10.52, which is considered extended relative to its 30-day fair value range of $9.65 to $10.40.
Technical Outlook: Technically, ICCC is showing sideways momentum. Immediate support is located at $9.60, while resistance sits at $10.88.
Market Sentiment: ICCC scores 13/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $14.00 (+33.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ICCC is showing sideways momentum. Immediate support is located at $9.60, while resistance sits at $10.88.
Market Sentiment: ICCC scores 13/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $14.00 (+33.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$9.65 -
$10.40
Company Quality Score
40/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
26.3%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (13/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 33.1% below Wall St target ($14.00)
- WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$9.65 -
$10.40
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$9.60
Resistance Level
$10.89
Current Trend
Sideways
Technical data as of
Oct 21, 2026
Fundamental Context
Wall Street Target
$14.00
(+33.1%)
Revenue Growth (YoY)
11.5%
Earnings Growth (YoY)
259.9%
Profit Margin
2.6%
Share & Embed Analysis
Last updated: October 22, 2026 8:28 AM ET
Data refreshes hourly during market hours. Next update: 9:28 AM
Data refreshes hourly during market hours. Next update: 9:28 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICCC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$295 | 56 HOLD |
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$864 | 47 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$31 | 71 BUY |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
20 analysts |
$650 | 50 HOLD |
|
ELVN
Enliven Therapeutics Inc. |
STRONG BUY
14 analysts |
$74 | 63 BUY |
